Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sheraz Y, Cheema"'
Publikováno v:
Journal of Psychiatric Research. 154:209-218
Canada exhibits one of highest lifetime prevalence for post-traumatic stress disorder (PTSD), but the etiology of this debilitating mental health condition still remains largely unknown. This study aims to examine the genetics of PTSD in the Canadian
Autor:
Clement C. Zai, Arun K. Tiwari, Gwyneth C. Zai, Natalie Freeman, Jennie G. Pouget, James Greco, Maria Tampakeras, Sajid A. Shaikh, Deanna Herbert, Heather Emmerson, Sheraz Y. Cheema, Nicole Braganza, Daniel J. Müller, Aristotle N. Voineskos, Gary Remington, James L. Kennedy
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Tardive dyskinesia (TD) is a movement disorder that may develop in schizophrenia patients being treated long-term with antipsychotic medication. TD interferes with voluntary movements and leads to stigma, and can be associated with treatment non-adhe
Externí odkaz:
https://doaj.org/article/33984d43103d4401aacfdc450e8eeebb
Autor:
Clement C. Zai, Frankie H. Lee, Arun K. Tiwari, Justin Y. Lu, Vincenzo de Luca, Miriam S. Maes, Deanna Herbert, Anashe Shahmirian, Sheraz Y. Cheema, Gwyneth C. Zai, Anupama Atukuri, Michael Sherman, Sajid A. Shaikh, Maria Tampakeras, Natalie Freeman, Nicole King, Daniel J. Müller, Lior Greenbaum, Bernard Lerer, Aristotle N. Voineskos, Steven G. Potkin, Jeffrey A. Lieberman, Herbert Y. Meltzer, Gary Remington, James L. Kennedy
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Tardive dyskinesia (TD) is a movement disorder that may occur after extended use of antipsychotic medications. The etiopathophysiology is unclear; however, genetic factors play an important role. The Perlecan (HSPG2) gene was found to be significantl
Externí odkaz:
https://doaj.org/article/46e3b779887e4bbd8b0d7bcb1200e1c3
Autor:
Jeffrey A. Lieberman, Herbert Y. Meltzer, Daniel J. Müller, Steven G. Potkin, Heather Emmerson, Aristotle N. Voineskos, Arun K. Tiwari, Gwyneth Zai, James L. Kennedy, Clement C. Zai, Sheraz Y. Cheema, Nicole King, Maria Tampakeras, Vincenzo De Luca, Natalie Freeman, Deanna Herbert, Justin Y. Lu, Gary Remington
Publikováno v:
Pharmacogenomics. 21:1065-1072
Background: Tardive dyskinesia (TD) is an iatrogenic involuntary movement disorder occurring after extended antipsychotic use with unclear pathogenesis. CYP2D6 is a liver enzyme involved in antipsychotic metabolism and a well-studied gene candidate f
Autor:
Julie George, Samantha Wells, Michael Danesi, Maria Tampakeras, Sheraz Y. Cheema, Clement C. Zai, Trehani M. Fonseka, Sajid A. Shaikh, Jürgen Rehm, Natalie Freeman, Gwyneth Zai, David Irwin, James L. Kennedy
Publikováno v:
Psychiatry Research. 275:247-252
Suicide claims over 800,000 lives each year worldwide. Suicide rates in indigenous populations in Canada are about double that of the national average, making it a serious public health issue. Numerous factors are involved in suicide risk, including
Autor:
Justin Y, Lu, Arun K, Tiwari, Natalie, Freeman, Gwyneth C, Zai, Vincenzo de, Luca, Daniel J, Müller, Maria, Tampakeras, Deanna, Herbert, Heather, Emmerson, Sheraz Y, Cheema, Nicole, King, Aristotle N, Voineskos, Steven G, Potkin, Jeffrey A, Lieberman, Herbert Y, Meltzer, Gary, Remington, James L, Kennedy, Clement C, Zai
Publikováno v:
Pharmacogenomics
BACKGROUND: Tardive dyskinesia (TD) is an iatrogenic involuntary movement disorder occurring after extended antipsychotic use with unclear pathogenesis. CYP2D6 is a liver enzyme involved in antipsychotic metabolism and a well-studied gene candidate f
Autor:
Arun K. Tiwari, Deanna Herbert, Ruth Baidya, Sarah E. Groleau, Maria Neves-Pereira, Clement C. Zai, Nicole King, Daniel J. Müller, Anashe Shahmirian, James L. Kennedy, Sheraz Y. Cheema
Publikováno v:
Journal of Psychiatric Research. 96:265-272
Objective Pharmacotherapy is one of the primary treatments for psychiatric disorders. Given the variation in individual response, a more personalized approach is needed. This paper will discuss methods for user-friendly referrals, recruitment criteri
Publikováno v:
European Neuropsychopharmacology. 29:S892
Background Despite evidence of public health concerns for overuse of benzodiazepines and sleep medications in the psychiatric population, reliable data on these prescribed medication use remain unavailable. Prescription rates for sleep aids and benzo
Autor:
Nicole Braganza, Clement C. Zai, Catherine Passariello, Lisa M. Brown, Arun K. Tiwari, Daniel J. Mueller, James L. Kennedy, Bryan Dechairo, Sheraz Y. Cheema, Gwyneth Zai
Publikováno v:
European Neuropsychopharmacology. 29:S933
Background Controlled substance prescription use and abuse in the United States has become a public health epidemic. Specifically, benzodiazepine abuse in 2013 has increased as much 400 percent since 1996. Generalized Anxiety Disorder (GAD) was the m